Extensively drug resistance (XDR) tb is not always fatal
Jain, N.K.; Agnihotri, S.P.; Sharma, K.K.; Gupta, S.; Gupta, P.
Indian Journal of Tuberculosis 56(1): 48-50
2009
ISSN/ISBN: 0019-5707 PMID: 19402272 Document Number: 634003
The chance of incidence of XDR TB is on the rise due to improper use of second line anti-tubercular drugs. XDR-TB is very difficult to treat successfully and is often referred to as "virtually untreatable form of TB". We herein report a case of XDR TB confirmed by bacteriological examination in a WHO recognised laboratory who after 12 months of regular treatment improved both clinically and radiologically with sputum smear conversion. To the best of our knowledge, there has been no previous report of any similar case in literature.
Document emailed within 1 workday
Related Documents
Olson, D.P.; Day, C.L.; Magula, N.P.; Sahid, F.; Moosa, M.-Y.S. 2007: Cutaneous extensively drug-resistant tuberculosis American Journal of Tropical Medicine and Hygiene 77(3): 551-554Christophersen, M.S.øb.; Svensson, E.; Kristensen, S.H. 2015: First case of extensively drug-resistant tuberculosis in Denmark Ugeskrift for Laeger 177(17)
Dheda, K. 2009: Extensively drug-resistant Mycobacterium tuberculosis: what are these bugs up to in India? Indian Journal of Medical Research 130(4): 357-358
Phua, C.K.; Chee, C.B.E.; Chua, A.P.G.; Gan, S.H.; Ahmed, A.D.B.; Wang, Y.T. 2011: Managing a case of extensively drug-resistant (XDR) pulmonary tuberculosis in Singapore Annals of the Academy of Medicine Singapore 40(3): 132-135
Puri, M.M.; Kumar, A.; Aneja, P.; Gupta, R.; Kumar, L.; Sarin, R. 2019: Tetany in an Extensively Drug Resistant Tuberculosis (XDR-TB) Patient Treated with Capreomycin Journal of the Association of Physicians of India 67(8): 79-82
Mlambo, C.K.; Warren, R.M.; Poswa, X.; Victor, T.C.; Duse, A.G.; Marais, E. 2008: Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 12(1): 99-104
Okumura, M.; Yoshiyama, T.; Ogata, H.; Morimoto, K.; Kokuto, H.; Kurashima, A.; Kudoh, S. 2011: Factors related to the occurrence of multi- (extensively-) drug resistant tuberculosis (M/XDR-TB) in our hospital Kekkaku: 86(11): 863-868
Chuchottaworn, C. 2010: Extensively drug resistant tuberculosis (XDR-TB) in Chest Disease Institute, 1997-2005 Journal of the Medical Association of Thailand 93(1): 34-37
Andrews, J.R.; Shah, N.S.; Weissman, D.; Moll, A.P.; Friedland, G.; Gandhi, N.R. 2010: Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community Plos one 5(12): E15735
Goldman, R.C.; Plumley, K.V.; Laughon, B.E. 2007: The evolution of extensively drug resistant tuberculosis (XDR-TB): history, status and issues for global control Infectious Disorders Drug Targets 7(2): 73-91
O'Donnell, M.R.; Padayatchi, N.; Master, I.; Osburn, G.; Horsburgh, C.R. 2009: Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 13(7): 855-861
Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F. 2013: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network Antiviral Therapy 18(6): 831-836
Hamers, R.L.; Schuurman, R.; Sigaloff, K.C.E.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Ive, P.; Botes, M.E.; Wellington, M.; Osibogun, A.; Wit, F.W.; van Vugt, M.èl.; Stevens, W.S.; de Wit, T.F.R. 2012: Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study LANCET. Infectious Diseases 12(4): 307-317
Kawada, H.; Yamazato, M.; Shinozawa, Y.; Suzuki, K.; Otani, S.; Ouchi, M.; Miyairi, M. 2008: Achievement of sputum culture negative conversion by minocycline in a case with extensively drug-resistant pulmonary tuberculosis Kekkaku: 83(11): 725-728
Choy, B.K.; McClarty, G.A.; Chan, A.K.; Thelander, L.; Wright, J.A. 1988: Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations Cancer Research 48(8): 2029-2035
Bertagnolio, S.; Rodriguez-Diaz, R.A.; Fuentes-Romero, L.L.; Bennett, D.E.; Viveros-Rogel, M.; Hart, S.; Pilon, R.; Sandstrom, P.; Soto-Ramirez, L.E. 2012: Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S328-S333
Horsburgh, C.Robert. 2008: Primary transmission of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected persons: what does the future hold in store? Journal of Infectious Diseases 198(11): 1577-1578
Wang, F. 2006: To enhance the research of antibiotic resistance and infection caused by drug-resistance bacteria Zhonghua Yi Xue Za Zhi 86(9): 579-580
Baba, H. 1994: Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin Kekkaku: 69(6): 387-396
Danks, M.K.; Yalowich, J.C.; Beck, W.T. 1987: Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26) Cancer Research 47(5): 1297-1301